JP4648491B2 - ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤 - Google Patents

ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤 Download PDF

Info

Publication number
JP4648491B2
JP4648491B2 JP2010084827A JP2010084827A JP4648491B2 JP 4648491 B2 JP4648491 B2 JP 4648491B2 JP 2010084827 A JP2010084827 A JP 2010084827A JP 2010084827 A JP2010084827 A JP 2010084827A JP 4648491 B2 JP4648491 B2 JP 4648491B2
Authority
JP
Japan
Prior art keywords
drug
solid preparation
iron oxide
present
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010084827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010260851A (ja
JP2010260851A5 (https=
Inventor
潤 杉下
和枝 大内
康裕 石川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Priority to JP2010084827A priority Critical patent/JP4648491B2/ja
Publication of JP2010260851A publication Critical patent/JP2010260851A/ja
Publication of JP2010260851A5 publication Critical patent/JP2010260851A5/ja
Application granted granted Critical
Publication of JP4648491B2 publication Critical patent/JP4648491B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2010084827A 2009-04-10 2010-04-01 ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤 Active JP4648491B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010084827A JP4648491B2 (ja) 2009-04-10 2010-04-01 ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009095536 2009-04-10
JP2010084827A JP4648491B2 (ja) 2009-04-10 2010-04-01 ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤

Publications (3)

Publication Number Publication Date
JP2010260851A JP2010260851A (ja) 2010-11-18
JP2010260851A5 JP2010260851A5 (https=) 2011-01-06
JP4648491B2 true JP4648491B2 (ja) 2011-03-09

Family

ID=42936331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010084827A Active JP4648491B2 (ja) 2009-04-10 2010-04-01 ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤

Country Status (2)

Country Link
JP (1) JP4648491B2 (https=)
WO (1) WO2010117050A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016210760A (ja) * 2015-04-28 2016-12-15 大原薬品工業株式会社 光安定性を向上したシロドシン含有着色錠剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5844573B2 (ja) * 2011-08-10 2016-01-20 共和薬品工業株式会社 ピタバスタチンを含有する錠剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000191516A (ja) * 1998-10-23 2000-07-11 Taisho Pharmaceut Co Ltd 経口固形組成物
JP5611502B2 (ja) * 2004-04-08 2014-10-22 協和発酵キリン株式会社 ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤
JP4214128B2 (ja) * 2005-04-27 2009-01-28 大日本住友製薬株式会社 光安定性の向上した組成物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016210760A (ja) * 2015-04-28 2016-12-15 大原薬品工業株式会社 光安定性を向上したシロドシン含有着色錠剤
JP2018070659A (ja) * 2015-04-28 2018-05-10 大原薬品工業株式会社 光安定性を向上したシロドシン含有着色錠剤
JP2018123146A (ja) * 2015-04-28 2018-08-09 大原薬品工業株式会社 光安定性を向上したシロドシン含有着色錠剤
JP2020200348A (ja) * 2015-04-28 2020-12-17 大原薬品工業株式会社 光安定性を向上したシロドシン含有着色錠剤

Also Published As

Publication number Publication date
WO2010117050A1 (ja) 2010-10-14
JP2010260851A (ja) 2010-11-18

Similar Documents

Publication Publication Date Title
US20210228722A1 (en) Quinoline derivative-containing pharmaceutical composition
JP6053425B2 (ja) ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤
BR112020021059A2 (pt) formulação sólida tendo excelente estabilidade
JP6680297B2 (ja) 経口投与用医薬組成物
WO2017006855A1 (ja) 安定な経口投与用医薬組成物
EP2524688B1 (en) Composition for modified release comprising ranolazine
JP2003155232A (ja) 不快な臭いが低減されたｌ−システイン配合固形製剤およびその製造方法
JP4648491B2 (ja) ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤
JPWO2016088816A1 (ja) 酢酸亜鉛水和物錠及びその製造方法
CA2873961C (en) Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
IL278161B1 (en) Solid dosage form with excellent stability
CN107106568B (zh) 稠合氨基二氢噻嗪衍生物的药物组合物
JP4413866B2 (ja) ジアリールビニレン化合物の安定化方法
WO2020111089A1 (ja) 医薬組成物
JP2003128543A (ja) アスコルビン酸またはその塩およびパントテン酸カルシウムを含有する固形製剤およびその製造方法
KR101406265B1 (ko) 안정성이 개선된 프라미펙솔을 함유하는 약제학적 조성물 및 이의 제조방법
JP7506475B2 (ja) フェブキソスタット製剤
JP2008105969A (ja) 酒石酸ゾルピデム組成物
HK1167607B (en) Quinoline derivative-containing pharmaceutical composition
HK1169599B (en) Quinoline derivative-containing pharmaceutical composition

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101020

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101020

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20101020

TRDD Decision of grant or rejection written
A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20101101

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101109

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101209

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131217

Year of fee payment: 3

R151 Written notification of patent or utility model registration

Ref document number: 4648491

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131217

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141217

Year of fee payment: 4

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250